Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Cash from Operations (Quarterly): -6.322M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.322M |
| September 30, 2023 | -5.841M |
| June 30, 2023 | -4.715M |
| March 31, 2023 | -6.959M |
| December 31, 2022 | -5.405M |
| September 30, 2022 | -6.817M |
| June 30, 2022 | -4.699M |
| March 31, 2022 | -8.184M |
| December 31, 2021 | -5.877M |
| September 30, 2021 | -5.095M |
| June 30, 2021 | -5.329M |
| March 31, 2021 | -4.574M |
| December 31, 2020 | 5.469M |
| September 30, 2020 | -1.937M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.998M |
| March 31, 2020 | -5.918M |
| December 31, 2019 | -4.020M |
| September 30, 2019 | -3.859M |
| June 30, 2019 | -5.144M |
| March 31, 2019 | -5.897M |
| December 31, 2018 | -4.106M |
| September 30, 2018 | -3.574M |
| June 30, 2018 | -3.040M |
| March 31, 2018 | -2.391M |
| December 31, 2017 | -1.993M |
| September 30, 2017 | -0.8247M |
| June 30, 2017 | -1.044M |
| March 31, 2017 | -0.8689M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.184M
Minimum
Mar 2022
5.469M
Maximum
Dec 2020
-4.696M
Average
-5.144M
Median
Jun 2019
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Alpine Immune Sciences Inc | -18.97M |
| Lantern Pharma Inc | -3.385M |
| Oragenics Inc | -1.102M |
| MAIA Biotechnology Inc | -3.992M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.1452M |
| Cash from Financing (Quarterly) | 0.6143M |
| Free Cash Flow | -27.81M |
| Free Cash Flow Per Share (Quarterly) | -0.1335 |
| Free Cash Flow to Equity (Quarterly) | -6.652M |
| Free Cash Flow Yield | -67.12% |